Pyrroler
Filtrerade sökresultat
Difluoro Atorvastatin Calcium Salt, TRC
CAS: 693793-53-2 Molekylformel: 2 C33 H33 F2 N2 O5 . Ca Molekylvikt (g/mol): 1191.32 Synonym: 1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-,Atorvastatin Related Compound C (USP),(3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-(1-methylethyl)-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt,Fluoroatorvastatin calcium salt IUPAC-namn: calcium;(3R,5R)-7-[2,3-bis(4-fluorophenyl)-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate LEDER: [Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccc(F)cc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccc(F)cc7)c(c8ccc(F)cc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)[O-]
| Molekylformel | 2 C33 H33 F2 N2 O5 . Ca |
|---|---|
| IUPAC-namn | calcium;(3R,5R)-7-[2,3-bis(4-fluorophenyl)-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate |
| CAS | 693793-53-2 |
| LEDER | [Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccc(F)cc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccc(F)cc7)c(c8ccc(F)cc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)[O-] |
| Molekylvikt (g/mol) | 1191.32 |
| Synonym | 1H-Pyrrole-1-heptanoic acid, 2,3-bis(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-,Atorvastatin Related Compound C (USP),(3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-(1-methylethyl)-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt,Fluoroatorvastatin calcium salt |
Atorvastatin Calcium Salt Trihydrate, TRC
CAS: 344423-98-9 Molekylformel: 2 C33 H34 F N2 O5 . Ca . 3 H2 O Molekylvikt (g/mol): 1209.39 Synonym: Atorvastatin calcium trihydrate,Calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate trihydrate,1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt, hydrate (2:1:3), (βR,δR)-,1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), trihydrate, (βR,δR)- (9CI),Atorvastatin hemicalcium sesquihydrate,Atorvastatin hemicalcium trihydrate IUPAC-namn: calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate;trihydrate LEDER: O.O.O.[Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccccc7)c(c8ccc(F)cc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)[O-]
| Molekylformel | 2 C33 H34 F N2 O5 . Ca . 3 H2 O |
|---|---|
| IUPAC-namn | calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate;trihydrate |
| CAS | 344423-98-9 |
| LEDER | O.O.O.[Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccccc7)c(c8ccc(F)cc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)[O-] |
| Molekylvikt (g/mol) | 1209.39 |
| Synonym | Atorvastatin calcium trihydrate,Calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate trihydrate,1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt, hydrate (2:1:3), (βR,δR)-,1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), trihydrate, (βR,δR)- (9CI),Atorvastatin hemicalcium sesquihydrate,Atorvastatin hemicalcium trihydrate |
Defluoro Atorvastatin Calcium Salt, TRC
CAS: 433289-83-9 Molekylformel: 2 C33 H35 N2 O5 . Ca Molekylvikt (g/mol): 1119.36 Synonym: 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-,Desfluoroatorvastatin Calcium Salt IUPAC-namn: calcium;(3R,5R)-7-[2,3-diphenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate LEDER: [Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccccc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccccc7)c(c8ccccc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)[O-]
| Molekylformel | 2 C33 H35 N2 O5 . Ca |
|---|---|
| IUPAC-namn | calcium;(3R,5R)-7-[2,3-diphenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate |
| CAS | 433289-83-9 |
| LEDER | [Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccccc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccccc7)c(c8ccccc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)[O-] |
| Molekylvikt (g/mol) | 1119.36 |
| Synonym | 1H-Pyrrole-1-heptanoic acid, β,δ-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-,Desfluoroatorvastatin Calcium Salt |
O-Methyl Atorvastatin Calcium Salt, TRC
CAS: 887196-29-4 Molekylformel: 2 C34 H36 F N2 O5 . Ca Molekylvikt (g/mol): 1183.39 Synonym: 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-δ-hydroxy-β-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-,Calcium (βR,δR)-2-(4-fluorophenyl)-δ-hydroxy-β-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2),(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic acid calcium salt,3-O-Methylatorvastatin calcium salt IUPAC-namn: calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-5-hydroxy-3-methoxyheptanoate LEDER: [Ca+2].CO[C@H](C[C@H](O)CCn1c(C(C)C)c(C(=O)Nc2ccccc2)c(c3ccccc3)c1c4ccc(F)cc4)CC(=O)[O-].CO[C@H](C[C@H](O)CCn5c(C(C)C)c(C(=O)Nc6ccccc6)c(c7ccccc7)c5c8ccc(F)cc8)CC(=O)[O-]
| Molekylformel | 2 C34 H36 F N2 O5 . Ca |
|---|---|
| IUPAC-namn | calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-5-hydroxy-3-methoxyheptanoate |
| CAS | 887196-29-4 |
| LEDER | [Ca+2].CO[C@H](C[C@H](O)CCn1c(C(C)C)c(C(=O)Nc2ccccc2)c(c3ccccc3)c1c4ccc(F)cc4)CC(=O)[O-].CO[C@H](C[C@H](O)CCn5c(C(C)C)c(C(=O)Nc6ccccc6)c(c7ccccc7)c5c8ccc(F)cc8)CC(=O)[O-] |
| Molekylvikt (g/mol) | 1183.39 |
| Synonym | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-δ-hydroxy-β-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, calcium salt (2:1), (βR,δR)-,Calcium (βR,δR)-2-(4-fluorophenyl)-δ-hydroxy-β-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoate (1:2),(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-5-hydroxy-3-methoxyheptanoic acid calcium salt,3-O-Methylatorvastatin calcium salt |
(3S,5S)-Atorvastatin Sodium Salt, TRC
CAS: 1428118-38-0 Molekylformel: C33 H34 F N2 O5 . Na Molekylvikt (g/mol): 580.62 Synonym: 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, sodium salt (1:1), (βS,δS)-,(3S,5S)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt,(βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid sodium salt (1:1),(3S,5S)-Atorvastatin sodium salt,ent-Atorvastatin sodium salt,Atorvastatin Imp. E (EP) as Sodium Salt IUPAC-namn: sodium;(3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate LEDER: [Na+].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@H](O)C[C@H](O)CC(=O)[O-]
| Molekylformel | C33 H34 F N2 O5 . Na |
|---|---|
| IUPAC-namn | sodium;(3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate |
| CAS | 1428118-38-0 |
| LEDER | [Na+].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@H](O)C[C@H](O)CC(=O)[O-] |
| Molekylvikt (g/mol) | 580.62 |
| Synonym | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, sodium salt (1:1), (βS,δS)-,(3S,5S)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt,(βS,δS)-2-(4-Fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid sodium salt (1:1),(3S,5S)-Atorvastatin sodium salt,ent-Atorvastatin sodium salt,Atorvastatin Imp. E (EP) as Sodium Salt |
(3R,5S)-Atorvastatin Sodium Salt, TRC
CAS: 131275-93-9 Molekylformel: C33 H34 F N2 O5 . Na Molekylvikt (g/mol): 580.62 Synonym: 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, monosodium salt, (R*,S*)- (9CI),(3RS,5SR)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt,Atorvastatin Calcium Trihydrate Imp. B (EP) as Sodium Salt IUPAC-namn: sodium;(3R,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate LEDER: [Na+].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@H](O)C[C@@H](O)CC(=O)[O-]
| Molekylformel | C33 H34 F N2 O5 . Na |
|---|---|
| IUPAC-namn | sodium;(3R,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate |
| CAS | 131275-93-9 |
| LEDER | [Na+].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@H](O)C[C@@H](O)CC(=O)[O-] |
| Molekylvikt (g/mol) | 580.62 |
| Synonym | 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, monosodium salt, (R*,S*)- (9CI),(3RS,5SR)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt,Atorvastatin Calcium Trihydrate Imp. B (EP) as Sodium Salt |
Fluvastatin Sodium Salt(Relative Stereochemistry), TRC
CAS: 93957-55-2 Molekylformel: C24 H25 F N O4 . Na Molekylvikt (g/mol): 433.45 Synonym: Fluvastatin Sodium,(3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt (1:1),[R*,S*-(E)]-(±)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt,(3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt,Almastatin,Canef,Cranoc,Fluindostatin,Fluvastatin sodium,Fractal,Lescol,Lescol XL,Lochol,Locol,Vastin,XU 62-320 IUPAC-namn: sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate LEDER: [Na+].CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)[O-])c(c2ccc(F)cc2)c3ccccc13
| Molekylformel | C24 H25 F N O4 . Na |
|---|---|
| IUPAC-namn | sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate |
| CAS | 93957-55-2 |
| LEDER | [Na+].CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)[O-])c(c2ccc(F)cc2)c3ccccc13 |
| Molekylvikt (g/mol) | 433.45 |
| Synonym | Fluvastatin Sodium,(3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt (1:1),[R*,S*-(E)]-(±)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt,(3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt,Almastatin,Canef,Cranoc,Fluindostatin,Fluvastatin sodium,Fractal,Lescol,Lescol XL,Lochol,Locol,Vastin,XU 62-320 |
4-Hydroxy Atorvastatin Hemicalcium Salt, TRC
CAS: 1263176-34-6 Molekylformel: C66H68CaF2N4O12 Molekylvikt (g/mol): 1187.34 Synonym: (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrole-1-heptanoic Acid Hemicalcium Salt,p-Hydroxyatorvastatin Hemicalcium Salt LEDER: OC1=CC=C(NC(C2=C(C(C)C)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C3=CC=C(F)C=C3)=C2C4=CC=CC=C4)=O)C=C1.[Ca+2]
| Molekylformel | C66H68CaF2N4O12 |
|---|---|
| CAS | 1263176-34-6 |
| LEDER | OC1=CC=C(NC(C2=C(C(C)C)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C3=CC=C(F)C=C3)=C2C4=CC=CC=C4)=O)C=C1.[Ca+2] |
| Molekylvikt (g/mol) | 1187.34 |
| Synonym | (βR,δR)-2-(4-Fluorophenyl)-β,δ-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrole-1-heptanoic Acid Hemicalcium Salt,p-Hydroxyatorvastatin Hemicalcium Salt |
TMC647055 Choline salt, MedChemExpress
MedChemExpress TMC647055 choline salt is a cell-permeating, selective HCV NS5B inhibitor, eliciting a mean IC50 of 34 nM, as assessed in the RdRp primer-dependent transcription assay.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C37H53N5O8S |
|---|---|
| Rekommenderad förvaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Formel vikt | 727.91 |
| Hållbarhet | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Löslighetsinformation | DMSO : ≥ 43 mg/mL (59.07 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| LEDER | OCC[N+](C)(C)C.COC1=CC2=C(C=C1)C3=C(C4CCCCC4)C5=CC=C(C6=O)C=C5N3CC(C(N(C)CCOCCN(S(N6)(=O)=O)C)=O)=C2.[OH-] |
| Molekylvikt (g/mol) | 727.91 |
| Kemiskt namn eller material | TMC647055 Choline salt |
| Procent renhet | 98.06% |
| För användning med (applikation) | COVID-19-anti-virus |
Ketorolac tromethamine salt, MedChemExpress
MedChemExpress Ketorolac tromethamine salt (RS37619 tromethamine salt) is a non-steroidal anti-inflammatory agent, acting as a nonselective COX inhibitor, with IC50s of 20 nM for COX-1 and 120 nM for COX-2.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C19H24N2O6 |
|---|---|
| Rekommenderad förvaring | 4°C, sealed storage, away from moisture and light∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture and light) |
| Formel vikt | 376.4 |
| Hållbarhet | 4°C, sealed storage, away from moisture and light∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture and light) |
| Hälsofara 1 | H301∣H315∣H319∣H335 |
| Löslighetsinformation | H2O : 100 mg/mL (265.67 mM; Need ultrasonic) ∣DMSO : ≥ 30 mg/mL (79.70 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Powder |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 74103-07-4 |
| LEDER | O=C(C1C2=CC=C(C(C3=CC=CC=C3)=O)N2CC1)O.OCC(CO)(N)CO |
| Molekylvikt (g/mol) | 376.4 |
| Synonym | Ketorolac Tromethamine Ketorolac tris salt RS37619 tromethamine salt |
| Kemiskt namn eller material | Ketorolac tromethamine salt |
| Procent renhet | 99.52% |
| För användning med (applikation) | COVID-19-immunoregulation |
Zomepirac sodium salt, MedChemExpress
MedChemExpress Zomepirac sodium salt (McN-2783-21-98) is a potent prostaglandin biosynthesis inhibitor. Zomepirac sodium salt is a non-steroidal anti-inflammatory drug (NSAID). Zomepirac sodium salt can cause immune-mediated liver injury.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C15H13ClNNaO3 |
|---|---|
| Rekommenderad förvaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Formel vikt | 313.71 |
| Hållbarhet | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Hälsofara 1 | H300∣H311+H331 |
| Löslighetsinformation | DMSO : 100 mg/mL (318.77 mM; Need ultrasonic) ∣H2O : 5 mg/mL (15.94 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 64092-48-4 |
| LEDER | O=C(O[Na])CC1=CC(C)=C(C(C2=CC=C(Cl)C=C2)=O)N1C |
| Molekylvikt (g/mol) | 313.71 |
| Synonym | McN-2783-21-98 |
| Kemiskt namn eller material | Zomepirac sodium salt |
| Procent renhet | 99.42% |
| För användning med (applikation) | COVID-19-immunoregulation |
BQ-788 sodium salt, MedChemExpress
MedChemExpress BQ-788 sodium salt is a potent and selective ETB receptor antagonist, inhibiting ET-1 binding to ETB receptors with an IC50 of 1.2 nM in human Girrardi heart cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C34H50N5NaO7 |
|---|---|
| Rekommenderad förvaring | -20°C, protect from light, stored under nitrogen∣In solvent : -80°C, 6 months∣-20°C, 1 month (protect from light, stored under nitrogen) |
| Formel vikt | 663.78 |
| Hållbarhet | -20°C, protect from light, stored under nitrogen∣In solvent : -80°C, 6 months∣-20°C, 1 month (protect from light, stored under nitrogen) |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : ≥ 43 mg/mL (64.78 mM) ∣H2O : 20 mg/mL (30.13 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 156161-89-6 |
| LEDER | CCCC[C@H](C(O[Na])=O)NC([C@@H](CC1=CN(C(OC)=O)C2=CC=CC=C12)NC([C@H](CC(C)(C)C)NC(N3[C@H](C)CCC[C@@H]3C)=O)=O)=O |
| Molekylvikt (g/mol) | 663.78 |
| Kemiskt namn eller material | BQ-788 sodium salt |
| Procent renhet | 98.03% |
| För användning med (applikation) | COVID-19-immunoregulation |
Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide, TRC
CAS: 1105067-87-5 Molekylformel: 2 C40 H47 F N3 O8 . Ca Molekylvikt (g/mol): 1473.71 Synonym: (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxyheptanoic Acid Calcium Salt (2:1),Calcium (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxyheptanoate (1:2) IUPAC-namn: calcium;(3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoate LEDER: [Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)NCC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccccc7)c(c8ccc(F)cc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)NCC[C@@H](O)C[C@@H](O)CC(=O)[O-]
| Molekylformel | 2 C40 H47 F N3 O8 . Ca |
|---|---|
| IUPAC-namn | calcium;(3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoate |
| CAS | 1105067-87-5 |
| LEDER | [Ca+2].CC(C)c1c(C(=O)Nc2ccccc2)c(c3ccccc3)c(c4ccc(F)cc4)n1CC[C@@H](O)C[C@@H](O)CC(=O)NCC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c5c(C(=O)Nc6ccccc6)c(c7ccccc7)c(c8ccc(F)cc8)n5CC[C@@H](O)C[C@@H](O)CC(=O)NCC[C@@H](O)C[C@@H](O)CC(=O)[O-] |
| Molekylvikt (g/mol) | 1473.71 |
| Synonym | (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxyheptanoic Acid Calcium Salt (2:1),Calcium (3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxyheptanoate (1:2) |
AZ7550 Mesylate, MedChemExpress
MedChemExpress AZ7550 Mesylate is an active metabolite of AZD9291 and inhibits the activity of IGF1R with an IC50 of 1.6 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C30H43N7O11S3 |
|---|---|
| Rekommenderad förvaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Formel vikt | 773.9 |
| Hållbarhet | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : 25 mg/mL (32.30 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Yellow |
| LEDER | CN1C=C(C2=NC(NC3=CC(NC(C=C)=O)=C(N(CCNC)C)C=C3OC)=NC=C2)C4=CC=CC=C41.O=S(O)(C)=O.O=S(O)(C)=O.O=S(O)(C)=O |
| Molekylvikt (g/mol) | 773.9 |
| Synonym | AZ7550 trimesylate salt |
| Kemiskt namn eller material | AZ7550 Mesylate |
| Procent renhet | 99.34% |
| För användning med (applikation) | Cancer-Kinase/protease |
Mebhydrolin napadisylate, MedChemExpress
MedChemExpress Mebhydrolin napadisylate is a specific histamine H1 receptor antagonist.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More